RYTM Stock Clocks Best Day In Nearly 16 Months On AstraZeneca $10B Bid Report
According to a report from The Wall Street Journal, citing people familiar with the matter, AstraZeneca offered $124 per share last month for Rhythm.
According to a report from The Wall Street Journal, citing people familiar with the matter, AstraZeneca offered $124 per share last month for Rhythm.